The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A 4 hydrolase (LTA 4 H), and shifts macrophage phenotype
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving and tissue homeostatic actions. Maresin 1 (MaR1; 7 R ,14 S ‐dihydroxy‐docosa‐4 Z ,8 E ,10 E ,12 Z ,16 Z ,19 Z ‐hexaenoic acid) is the first identified maresin. Here, we investigate formation, stereochemistry, and precursor role of 13,14‐epoxy‐docosahexaenoic acid, an intermediate in MaR1 biosynthesis. The 14‐lipoxygenation of DHA by human macrophage 12‐lipoxygenase (hm12‐LOX) gave 14‐hydro(peroxy)‐docosahexaenoic acid (14‐HpDHA), as well as several dihydroxy‐docosahexaenoic acids, implicating an epoxide intermediate formation by this enzyme. Using a stereo‐controlled synthesis, enantiomerically pure 13 S ,14 S ‐epoxy‐docosa‐4 Z ,7 Z ,9 E ,11 E ,16 Z ,19 Z ‐hexaenoic acid (13 S ,14 S ‐epoxy‐DHA) was prepared, and its stereochemistry was confirmed by NMR spectroscopy. When this 13 S ,14 S ‐epoxide was incubated with human macrophages, it was converted to MaR1. The synthetic 13 S ,14 S ‐epoxide inhibited leukotriene B 4 (LTB 4 ) formation by human leukotriene A 4 hydrolase (LTA 4 H) ~40% ( P <0.05) to a similar extent as LTA4 (~50%, P <0.05) but was not converted to MaR1 by this enzyme. 1 3S ,14 S ‐epoxy‐DHA also reduced (~60%; P <0.05) arachidonic acid conversion by hm12‐LOX and promoted conversion of M1 macrophages to M2 phenotype, which produced more MaR1 from the epoxide than M1. Together, these findings establish the biosynthesis of the 13 S ,14 S ‐epoxide, its absolute stereochemistry, its precursor role in MaR1 biosynthesis, and its own intrinsic bioactivity. Given its actions and role in MaR1 biosynthesis, this epoxide is now termed 13,14‐epoxy‐maresin (13,14‐eMaR) and exhibits new mechanisms in resolution of inflammation in its ability to inhibit proinflammatory mediator production by LTA4 hydrolase and to block arachidonate conversion by human 12‐LOX rather than merely terminating phagocyte involvement.—Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., Serhan, C. N. The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H) and shifts macrophage phenotype. FASEB J. 27, 2573–2583 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At least some of these lipid metabolites are produced by macrophages (101) and also signal to macrophages to reduce inflammatory and fibrogenic gene expression (102).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · cited 10×
“In the biosynthesis of MaR1, DHA undergoes 14S-lipoxygenation to give 14-HpDHA that is converted to 13S,14S-epoxy-DHA, a proposed intermediate that is then further transformed to MaR1 (8).”
BackgroundMethodInfluentialSelf-citationResolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695 · cited 1×
“The ability to identify resolvins revealed their remarkable protective actions, including their ability to enhance immune vigilance (23) and to stimulate host immune responses, lowering antibiotic requirements during infection (24).”
BackgroundSelf-citationInfection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664
Self-citationMacrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Serhan, C. N., Dalli, J., Karamnov, S., Choi, A., Park, C., Xu, Z., Ji, R., Zhu, M., & Petasis, N. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-201442 · Cited by 595 · cited 7×
“We next determined the identity of these DHA-derived products by assessing their respective MS-MS spectra and matching with synthetic and/or authentic standards (11).”
BackgroundInfluentialSelf-citationShimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576 · cited 1×
“3 min that corresponded to the known nonenzymatic hydrolysis products of LTA4 (3, 4) with the major peak at TR 5.”
Backgroundn–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Self-citationFatty acids and inflammation: The cutting edge between food and pharma
Calder, P. C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.085 · Cited by 516 · cited 1×
“It is now well appreciated that -3 fatty acids exert a positive bearing on several important aspects of cardiovascular disease (30, 31).”
BackgroundMetabolic oxidation regulates embryonic stem cell differentiation
Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sánchez-Ruiz, A., Benton, H. P., Trauger, S. A., Desponts, C., Ding, S., & Siuzdak, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.364 · Cited by 506
Cited by
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Self-citationInflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationProresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
Self-citationThe resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Self-citation
Metadata
- Authors
- Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Southern California (US)
- Karolinska Institutet (SE)
- Corresponding author
- Petasis, Nicos A.
- Serhan, Charles N.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-03-15
- Volume
- 27
- Issue
- 7
- Pages
- 2573-2583
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3688739
- OpenAlex
- W2100994932
- Cited by
- 283
- References
- 32
- Citations by year
- 2026: 20 · 2025: 14 · 2024: 13 · 2023: 25 · 2022: 23 · 2021: 23 · 2020: 30 · 2019: 19 · 2018: 28 · 2017: 26 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 4
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P01GM095467)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- maresin 1, epoxyeicosatrienoic acids, docosahexaenoic acid, 12-lipoxygenase, leukotriene A4 hydrolase, macrophage phenotype, leukotriene B4, specialized pro-resolving mediators, eicosanoid biosynthesis
- MeSH terms
- Arachidonate 12-Lipoxygenase, Cells, Cultured, Docosahexaenoic Acids, Epoxide Hydrolases, Humans, Leukotriene B4, Macrophages, Models, Chemical, Magnetic Resonance Spectroscopy, Molecular Structure, Arachidonic Acid, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A 4 hydrolase (LTA 4 H), and shifts macrophage phenotype. https://app.cochat.ai/papers/10.1096/fj.13-227728
- The paper
- Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N. (2013). The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A 4 hydrolase (LTA 4 H), and shifts macrophage phenotype. The FASEB Journal. https://doi.org/10.1096/fj.13-227728
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.